Metformin inhibits urothelial tumorigenesis in the UPII-mutant Ha-ras transgenic mouse model

Similar Items

• KAVA chalcone, Flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model
  od: Liu, Zhongbo, i dr.
  Izdano: (2013)
• High sensitivity of an Ha-RAS transgenic model of superficial bladder cancer to metformin is associated with ~ 240-fold higher drug concentration in urine than serum
  od: Liu, Zhongbo, i dr.
  Izdano: (2016)
• v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid.
  od: Leder, A, i dr.
  Izdano: (1990)
• Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis.
  od: Vassar, R, i dr.
  Izdano: (1992)
• Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model
  od: Li, Xuesen, i dr.
  Izdano: (2015)